[177Lu]Lu-PSMA-617-administration using totally implantable venous access port
"These findings suggest that [177Lu]Lu-PSMA-617 administration via TIVAP appears safe and effective, supporting its use in clinical practice particularly for patients with limited peripheral venous access" Lombard et al (2025).